Craig Grobstich

Regional Business Director - North Central - Rare Disease, Orphan Drug, Alnylam at Alnylam Pharmaceuticals - Cambridge, Massachusetts, US

Craig Grobstich's Colleagues at Alnylam Pharmaceuticals
Tiana Ositelu

Business Account Executive

Contact Tiana Ositelu

Nick Walzer

Senior Director Strategic Capabilities & Learning

Contact Nick Walzer

Amy Dell

Senior Research Associate

Contact Amy Dell

Cheryl Palinski

Associate Director, Talent Strategy

Contact Cheryl Palinski

James Lucie

Associate Director Supplier Relations

Contact James Lucie

View All Craig Grobstich's Colleagues
Craig Grobstich's Contact Details
HQ
(617) 551-8200
Location
Bettendorf, Iowa, United States
Company
Alnylam Pharmaceuticals
Craig Grobstich's Company Details
Alnylam Pharmaceuticals logo, Alnylam Pharmaceuticals contact details

Alnylam Pharmaceuticals

Cambridge, Massachusetts, US • 2460 Employees
SaaS

ALNYLAM IS LEADING THE RNAi REVOLUTION™ Alnylam is a leading independent biopharmaceutical company and the pioneer in RNA interference (RNAi) therapeutics – a revolutionary approach to treating diseases which “silences” the genes that cause or contribute to them. Founded in 2002 by a group of distinguished researchers and biotech leaders, Alnylam’s work over more than two decades has yielded the critical breakthroughs and advancements that have made the field of (RNAi) therapeutics possible. In 2018, our first commercial medicine, and the world’s first RNAi therapeutic was approved. Since then, four more Alnylam-developed medicines have been approved and we’re hard at work developing new therapies to treat both rare and prevalent diseases. We are a global and diverse company of 2,500+ people. We pride ourselves on fostering a fun, inclusive and dynamic work environment where employees can recognize their fullest potential. That's why we’re consistently ranked as a top employer by The Boston Globe (2015-23), Science Magazine (2018-23), Fast Company (Best Workplaces for Innovators 2020-23) and LinkedIn (2024). We are based in Cambridge, Massachusetts (U.S.), with offices throughout North America, Europe, Asia, and South America. See our social media community guidelines: https://bit.ly/2FcRhJy. Please note: If you wish to report an adverse event or product complaint, please email medinfo@alnylam.com or you may call us using the following telephone numbers: for North America, 877.ALNYLAM (877.256.9526), for Europe, +31 20 369 7861

Rna Therapeutics Innovative Treatments Ocular Disease Treatment
Details about Alnylam Pharmaceuticals
Frequently Asked Questions about Craig Grobstich
Craig Grobstich currently works for Alnylam Pharmaceuticals.
Craig Grobstich's role at Alnylam Pharmaceuticals is Regional Business Director - North Central - Rare Disease, Orphan Drug, Alnylam.
Craig Grobstich's email address is ***@alnylam.com. To view Craig Grobstich's full email address, please signup to ConnectPlex.
Craig Grobstich works in the SaaS industry.
Craig Grobstich's colleagues at Alnylam Pharmaceuticals are Tiana Ositelu, Akshay Vaishnaw, Nick Walzer, Amy Dell, Cheryl Palinski, Floris Homan, James Lucie and others.
Craig Grobstich's phone number is (617) 551-8200
See more information about Craig Grobstich